Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DARV32
|
|||
| Drug Name |
GP-2250
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Pancreatic cancer [ICD-11: 2C10; ICD-9: 157] | Phase 1/2 | [1] | |
| Company |
Geistlich
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03854110) Trial to Evaluate Safety and Tolerability of GP-2250 in Combination With Gemcitabine. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.